NEW YORK--(BUSINESS WIRE)--Hospital for Special Surgery (HSS) has been ranked No. 1 in the nation for orthopedics for a record-breaking 16th consecutive year and No. 3 in the nation for rheumatology ...
The medication, suzetrigine (JOURNAVX ® ), was FDA-approved in January 2025 and became available at HSS in April 2025. It is the first non-opioid pain reliever released in more than 25 years.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results